Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX1 | P51575 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | KCNMA1 | Q12791 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 4/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | DHODH | Q02127 | 1/20 | 0.39 |
| ▸ | CRHBP | P24387 | 1/20 | 0.39 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3213773 | 0.84 | PTGS1 (0.39) | P2RX1KMT2ALMNAMEN1SMN1; SMN2 | |
| SCHEMBL14850235 | 0.82 | P2RX1 (0.46) | P2RX1KMT2ALMNAL3MBTL1KCNMA1 | |
| SCHEMBL3209273 | 0.79 | LMNA (0.46) | KMT2ALMNAMEN1SMN1; SMN2RAB9A | |
| SCHEMBL14849968 | 0.79 | KMT2A (0.45) | P2RX1KMT2ALMNAL3MBTL1KCNMA1 | |
| SCHEMBL298242 | 0.78 | P2RX1 (0.44) | P2RX1KMT2ALMNAL3MBTL1KCNMA1 | |
| SCHEMBL13067830 | 0.76 | P2RX1 (0.42) | P2RX1KMT2ALMNAL3MBTL1KCNMA1 | |
| SCHEMBL3224790 | 0.75 | LMNA (0.44) | KMT2ALMNAMEN1SMN1; SMN2RAB9A | |
| SCHEMBL298914 | 0.75 | P2RX1 (0.41) | P2RX1KMT2ALMNAL3MBTL1KCNMA1 | |
| SCHEMBL1844350 | 0.75 | KCNMA1 (0.51) | P2RX1KMT2ALMNAL3MBTL1KCNMA1 | |
| SCHEMBL3226875 | 0.74 | LMNA (0.43) | KMT2ALMNAMEN1SMN1; SMN2RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2120556-B1 | INSECTICIDAL COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2016-03-09 | — | — | EP | disclosed |
| US-8389766-B2 | Insecticidal compounds | SYNGENTA CROP PROTECTION LLC (US) | 2013-03-05 | — | — | US | disclosed |
| US-8247594-B2 | Insecticidal compounds | SYNGENTA CROP PROTECTION LLC (US) | 2012-08-21 | — | — | US | disclosed |
| US-20100130601-A1 | INSECTICIDAL COMPOUNDS | SYNGENTA CROP PROTECTION, INC. (US) | 2010-05-27 | — | — | US | disclosed |
| US-20100056639-A1 | INSECTICIDAL COMPOUNDS | SYNGENTA CROP PROTECTION, INC. (US) | 2010-03-04 | — | — | US | disclosed |
| EP-2120556-A1 | INSECTICIDAL COMPOUNDS | Syngeta Participations AG (CH) | 2009-11-25 | — | — | EP | disclosed |
| EP-2114161-A1 | INSECTICIDAL COMPOUNDS | Syngeta Participations AG (CH) | 2009-11-11 | — | — | EP | disclosed |
| WO-2008107091-A1 | INSECTICIDAL COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2008-09-12 | — | — | WO | disclosed |
| WO-2008074427-A1 | INSECTICIDAL COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2008-06-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100130601-A1 | INSECTICIDAL COMPOUNDS | ACHE, NIT2, CHRM1 | P2RX1 528/4885KMT2A 2468/4885LMNA 1069/4885 |
| US-20100056639-A1 | INSECTICIDAL COMPOUNDS | ACHE, CHRM1, NIT2 | P2RX1 456/4885KMT2A 2178/4885LMNA 899/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.